Search For "ph"
Indian API companies to benefit as global customers try to reduce dependen
Updated : 5 years, 7 months ago IST
Mumbai (Maharashtra) [India], July 28 (ANI): India Ratings and Research (Ind-Ra) has said that Indian active pharmaceutical ingredient (API) companies will benefit from improving demand outlook in the United States.
Read More
India proved to be 'pharmacy of the world': Sadananda Gowda
Updated : 5 years, 7 months ago IST
New Delhi [India], July 28 (ANI): Union Minister for Chemicals and Fertilizers Sadananda Gowda on Monday said that India has proved that it is the "pharmacy of the world" in the ongoing COVID-19 pandemic.
Read More
Equity indices in the red, pharma and banking scrips dip
Updated : 5 years, 7 months ago IST
Mumbai (Maharashtra) [India], July 27 (ANI): Equity benchmark indices slipped during early hours on Monday mainly due to losses witnessed in pharma and banking stocks.
Read More
Foodgrains distributed to 2.64 lakh ration card holders in UP under Atmani
Updated : 5 years, 7 months ago IST
Lucknow (Uttar Pradesh) [India], July 26 (ANI): Additional Chief Secretary (Home) Awanish Kumar Awasthi on Sunday informed that 5.86 lakh units of free food grains have been distributed to 2.64 lakh ration card holders in the state under the Atmanirbhar Bharat Yojna's second phase.
Read More
Phase 5 of Vande Bharat Mission begins from Aug 1
Updated : 5 years, 7 months ago IST
New Delhi [India], July 26 (ANI): The fifth phase of the Government of India's 'Vande Bharat' mission, aimed at evacuating Indian nationals stranded in various foreign countries owing to restrictions on air travel, will begin early next month, August 1.
Read More
DMRC casts first pier at Keshopur on Janakpuri West-RK Ashram Phase-IV Met
Updated : 5 years, 7 months ago IST
New Delhi [India], July 26 (ANI): The Delhi Metro Rail Corporation (DMRC) started construction of Phase-IV of the Delhi Metro with the casting of the first pier of Janakpuri West to Ramakrishna Ashram Marg Metro corridor on Saturday night.
Read More
First part of phase-1 of Covaxin human trial completed at PGI Rohtak
Updated : 5 years, 7 months ago IST
Rohtak (Haryana) [India], July 26 (ANI): The first part of phase-1 of Covaxin human trial completed on Saturday at Post-Graduate Institute (PGI) of Medical Sciences, Rohtak, said Dr Savita Verma, principal investigator of the vaccine trial team.
Read More
Domestic pharma giant SII applies to DCGI for phase 2/3 clinical trial of
Updated : 5 years, 7 months ago IST
New Delhi [India], July 25 (ANI): In a development related to the COVID-19 vaccine, the Serum Institute of India (SII) has applied to the Drugs Controller General of India (DCGI) for conducting the Phase 2/3 human clinical trials for a potential coronavirus vaccine.
Read More
Cipla gets regulatory nod for launch of Ciplenza to treat mild to moderate
Updated : 5 years, 7 months ago IST
Mumbai (Maharashtra) [India], July 24 (ANI): Pharmaceutical major Cipla said on Friday it has been granted regulatory approval by the Drug Controller General of India (DCGI) for the launch of Favipiravir in the country under the brand name Ciplenza.
Read More
Sun Pharma's arm Taro achieves global resolution of US DoJ anti-trust prob
Updated : 5 years, 7 months ago IST
Mumbai (Maharashtra) [India], July 24 (ANI): Sun Pharmaceutical Industries said on Friday its US-based subsidiary Taro Pharmaceutical Inc has resolved all cases in connection with multi-year investigations by the Department of Justice's (DoJ's) Anti-trust Division and Civil Division into the
Read More
Aquapay appoints new CEO to lead next phase of Enterprise Payments growth
Updated : 5 years, 7 months ago IST
Mumbai (Maharashtra) [India] July 23 (ANI/PRNewswire): Enterprise Payments Major & Platform as a service (PaaS) specialist, Aquapay Payments Technologies (P) Ltd, announced today that Nitin Chavan has been appointed as Chief Executive Officer. Nitin joins Aquapay team with two decades of
Read More
Glenmark announces top-line results from phase 3 clinical trial of Favipir
Updated : 5 years, 7 months ago IST
Mumbai (Maharashtra) [India] July 23 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd - a global research-led pharmaceutical company - announced top-line results from a phase 3 clinical trial in mild to moderate COVID-19 patients, conducted across seven clinical sites in India.
Read More